Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Buy
51
XBI Quote, Financials, Valuation and Earnings
Last price:
$86.13
Seasonality move
:
2.48%
Day range:
$86.39 - $88.86
52-week range:
$81.14 - $105.47
Dividend yield:
0.15%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
6.4M
Avg. volume:
8.9M
1-year change:
-6.78%
Market cap:
--
Revenue:
--
EPS (TTM):
--
SPDR S&P Biotech ETF Number of Institutional Trades
SPDR S&P Biotech ETF Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
--
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
--
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SPDR S&P Biotech ETF Institutional Ownership
-
What Percentage Of XBI Is Owned by Institutions?
-- of XBI is owned by institutions.
-
How Many Institutions Own XBI Shares?
SPDR S&P Biotech ETF stock is owned by 0 institutional shareholders at this time.
-
Have Institutions Been Buying XBI Stock?
Yes, institutions have bought 0 shares of XBI in the last quarter.
-
Have Institutions Been Selling XBI Stock?
Yes, institutions have sold 0 shares of XBI over the last quarter.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
